Givosiran | Interleukin Related interleukin-related.com

Product Name :
Givosiran

Search keywords :
Givosiran

drugId :
null

Target Vo:
5 aminolevulinate synthase 1

Target Vo Short Name :
ALAS1

Moa_Name:
RNA interference

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Alnylam Pharmaceuticals Inc

Active Company_Name :
Alnylam Japan Kk

Active Indication_Name:
Porphyrias, Hepatic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ErbB 2 (YP6024) Mouse mAb manufacturer
Epratuzumab Biological Activity
Phospho-JAK2 (Tyr1007/1008) Antibody: Phospho-JAK2 (Tyr1007/1008) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to Phospho-JAK2 (Tyr1007/1008). It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts